首页> 外国专利> Pyrimidinone derivatives as therapeutic agents against acute and chronic inflammatory and ischemic remodeling

Pyrimidinone derivatives as therapeutic agents against acute and chronic inflammatory and ischemic remodeling

机译:嘧啶酮衍生物作为抗急性和慢性炎症和缺血重塑的治疗剂

摘要

Compounds of general formula (I) ** ** Formula wherein A represents a phenyl or pyridyl ring, R1, R2 and R3 independently represent each hydrogen, halogen, nitro, cyano, C1-C6 alkyl, hydroxy oalcoxi-C1-C6 alkyl, wherein the C1-C6 alkoxy-C1-C6 alkyl may be further substituted with one to three radicalesidénticos or different selected from the group consisting of halogen, hydroxy and alkoxy-C1-C4, R4 represents trifluoromethylcarbonyl, alkylcarbonyl-C1-C6 alkoxycarbonyl-C1-C6 alkyl, C1-C6-alkenoxycarbonyl, hydroxycarbonyl, aminocarbonyl, mono- or di-alkylaminocarbonyl-C1-C4, arylaminocarbonyl-C6-C10 arylcarbonyl, heteroarilocarbonilo, heterocyclylcarbonyl, heteroaryl, heterocyclyl or cyano, wherein the alkylcarbonyl-C1-C6 alkyl, C1-C6-elalcoxicarbonilo, the mono- and di-alkylaminocarbonyl-C1-C4 may be further substituted with one to tresradicales identical or different selected from the group consisting of cycloalkyl-C3 8 -cycloalkyl, hydroxy, alkoxy-C1 C4, alkoxycarbonyl-C1-C4 alkyl, hydroxycarbonyl, aminocarbonyl, mono- and di-alkylaminocarbonyl-C1-C4, alkylcarbonylamino-C1-C4 alkyl, (alkylcarbonyl-C1-C4) alkylamino-C1-C4 alkyl, cyano, amino, mono- and dialkylamino-C1-C4 alkyl, heteroaryl, heterocyclyl ytri- (alkyl C1-C6) alkylsilyl and in which the heteroarilocarbonilo, the heterocyclylcarbonyl, heteroaryl and heterociclilopueden further substituted with C1-C4, R5 represents alkyl -C1-C4, which may be substituted with one to three identical or different radicals seleccionadodel group consisting of halogen, hydroxy, C1-C6 alkoxy, alkenoxy-C1-C6 alkylthio-C1-C6-, amino, mono- and dialkylamino-C1-C6 alkyl, arylamino, hydroxycarbonyl, alkoxycarbonyl-C1-C6 and the radical -O-C1-C4 alkyl-O-C1-C4.
机译:通式(I)的化合物**其中A代表苯基或吡啶基环,R1,R2和R3独立地代表氢,卤素,硝基,氰基,C1-C6烷基,羟基邻苯二酚-C1-C6烷基,其中C 1 -C 6烷氧基-C 1 -C 6烷基可以进一步被1-3个或多个选自卤素,羟基和烷氧基-C 1 -C 4的基团取代,R 4代表三氟甲基羰基,烷基羰基-C 1 -C 6烷氧基羰基-C 1 -C 6烷基,C 1 -C 6烯氧基羰基,羟基羰基,氨基羰基,单或二烷基氨基羰基-C 1 -C 4,芳基氨基羰基-C 6 -C 10芳基羰基,杂芳烃基,杂环基羰基,杂芳基,杂环基或氰基,其中烷基羰基-C 1 -C 6烷基,C 1 -C 6-烯丙基羰基,单-和二-烷基氨基羰基-C 1 -C 4可以进一步被一个或多个选自相同或不同的四氢呋喃基取代,所述组选自环烷基-C 3-8-环烷基,羟基,烷氧基-C 1 C 4,烷氧基羰基-C1-C4烷基,Hy乙氧基羰基,氨基羰基,单和二烷基氨基羰基-C 1 -C 4,烷基羰基氨基-C 1 -C 4烷基,(烷基羰基-C 1 -C 4)烷基氨基-C 1 -C 4烷基,氰基,氨基,单和二烷基氨基-C 1 -C 4烷基,杂芳基,杂环基y-(烷基C 1 -C 6)烷基甲硅烷基,其中杂芳基碳基,杂环基羰基,杂芳基和杂环戊二烯基进一步被C 1 -C 4取代,R 5代表烷基-C 1 -C 4,其可以被1-3个相同或不同取代由卤素,羟基,C 1 -C 6烷氧基,链烯氧基-C 1 -C 6烷硫基-C 1 -C 6,氨基,单和二烷氨基-C 1 -C 6烷基,芳基氨基,羟基羰基,烷氧基羰基-C 1 -C 6组成的硒代亚硒酸酯基团和基团-O-C1-C4烷基-O-C1-C4。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号